ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Novo Nordisk A/S (NVO) shows an Average True Range (ATR) of 3.08 and an Enterprise Value of 4T. Its average trading volume over the past 3 months is 11.93M, indicating liquidity. These fundamental metrics provide insight into NVO's underlying financial health and market activity.
Novo Nordisk A/S (NVO) technical indicators as of July 31, 2025: the SMA 20 is -25.19%, SMA 50 at -28.44%, and SMA 200 at -40.03%. The RSI 14 value is 23.35, suggesting its current momentum. These technical analysis signals help assess NVO's price trends and potential future movements.
Novo Nordisk A/S (NVO) stock performance overview as of July 31, 2025: The 52-week high is $139.74 (currently -64.2% below), and the 52-week low is $49.6 (currently -6.5% above). Over the past year, NVO's performance is -60.87%, compared to the S&P 500's 17.04% change.
According to market data, Novo Nordisk A/S (NVO) stock's recent performance metrics show that over the last month, NVO is -27.51%, with a Year-to-Date (YTD) performance of -41.84%. Over the past year, the stock has seen a -60.87% change. These figures summarize NVO's price movements across various periods, reflecting its historical returns.
According to current financial data, NVO stock's P/E (TTM) ratio is 13.78, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for NVO, including P/S (4.75), P/B (10.40), and P/FCF (19.28), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.